LIN vs TECH
Linde plc Ordinary Shares (LIN) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the LIN and TECH stock pages for the full models.
Not investment advice.